Stephen S. Yoder
2023
In 2023, Stephen S. Yoder earned a total compensation of $1.4M as Chief Executive Officer at Pieris Pharmaceuticals, a 34% decrease compared to previous year.
Compensation breakdown
| Bonus | $146,149 |
|---|---|
| Option Awards | $614,818 |
| Salary | $584,595 |
| Other | $13,390 |
| Total | $1,358,952 |
Yoder received $614.8K in option awards, accounting for 45% of the total pay in 2023.
Yoder also received $146.1K in bonus, $584.6K in salary and $13.4K in other compensation.
Rankings
In 2023, Stephen S. Yoder's compensation ranked 874th out of 2,918 executives tracked by ExecPay. In other words, Yoder earned more than 70.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 874 out of 2,918 | 70th |
Division Manufacturing | 515 out of 1,608 | 68th |
Major group Chemicals And Allied Products | 351 out of 901 | 61st |
Industry group Drugs | 341 out of 864 | 61st |
Industry Pharmaceutical Preparations | 232 out of 622 | 63rd |
Source: SEC filing on November 6, 2024.
Yoder's colleagues
We found two more compensation records of executives who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2023.